alluvi-healthcare888059 - Profile

About me

Profile

Alluvi, previously BI 4744, represents a significant development in weight management therapy. This dual activator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide targets

https://alluvi-research.co.uk/product/alluvi-retatrutide-40mg-rd-only/